• xmlui.mirage2.page-structure.header.title
    • français
    • English
  • Help
  • Login
  • Language 
    • Français
    • English
View Item 
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

BIRDResearch centres & CollectionsBy Issue DateAuthorsTitlesTypeThis CollectionBy Issue DateAuthorsTitlesType

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors
Thumbnail

External referencing and pharmaceutical price negociation

Garcia Marinoso, Begona; Jelovac, Izabella; Olivella, Pau (2011), External referencing and pharmaceutical price negociation, Health Economics, 20, 6, p. 737-756. http://dx.doi.org/10.1002/hec.1630

View/Open
External_referencing.PDF (541.9Kb)
Type
Article accepté pour publication ou publié
Date
2011
Journal name
Health Economics
Volume
20
Number
6
Publisher
Wiley
Pages
737-756
Publication identifier
http://dx.doi.org/10.1002/hec.1630
Metadata
Show full item record
Author(s)
Garcia Marinoso, Begona
Jelovac, Izabella
Olivella, Pau
Abstract (EN)
External referencing (ER) imposes a price cap for pharmaceuticals, based on prices of identical or comparable products in foreign countries. Suppose a foreign country (F) negotiates prices with a pharmaceutical firm, whereas a home country (H) can either negotiate prices independently or implement ER, based on the foreign price. We show that country H prefers ER if copayments in H are relatively high. This preference is reinforced when H's population is small. Irrespective of relative country sizes, ER by country H harms country F. Our model is inspired by the wide European experience with this cost-containment policy. Namely, in Europe, drug authorization and price negotiations are carried out by separate agencies. We confirm our main results in two extensions. The first one allows for therapeutic competition between drugs. In the second one, drug authorization and price negotiation take place in a single agency.
Subjects / Keywords
pharmaceuticals; external referencing; price negotiation
JEL
L65 - Chemicals; Rubber; Drugs; Biotechnology
I18 - Government Policy; Regulation; Public Health

Related items

Showing items related by title and author.

  • Thumbnail
    Investigating Generic and Brand Name Pharmaceutical’s Market Shares and Prices in Tunisia 
    Chebbi, Houssem Eddine; Boujelbene, Younes; Ayadi, Inès (2008) Communication / Conférence
  • Thumbnail
    Gestion des connaissances et externalisation informatique. Apports managériaux et techniques pour l'amélioration du processus de transition : Cas de l'externalisation informatique dans un EPST 
    Grim-Yefsah, Malika (2012) Thèse
  • Thumbnail
    Sur les Coûts et Externalités de l'Intermédiation 
    Milone, Mario (2018-12-03) Thèse
  • Thumbnail
    Externalités de capital humain dans les marchés du travail locaux et évaluation d'une politique de développement universitaire. 
    Charruau, Paul (2022-06-29) Thèse
  • Thumbnail
    Agent-based Group Decision Making for Ordinal Classification : Preference Elicitation and Negociation-aggregation 
    Nefla, Ons (2021-06-30) Thèse
Dauphine PSL Bibliothèque logo
Place du Maréchal de Lattre de Tassigny 75775 Paris Cedex 16
Phone: 01 44 05 40 94
Contact
Dauphine PSL logoEQUIS logoCreative Commons logo